Philippe Bishop M.D.

Philippe Bishop MD is a seasoned medical professional with extensive experience in oncology and drug development. Currently serving as the Chief Medical Officer at Abdera Therapeutics since January 2024, Philippe Bishop previously held similar roles at Atreca, Inc. and Clover Biopharmaceuticals, where involvement included the development of novel vaccines and therapeutic candidates. Philippe Bishop co-founded aratinga.bio, focusing on innovative cancer immunotherapies. Additionally, Philippe Bishop has held leadership positions at Gilead Sciences, Genentech, Johnson & Johnson, sanofi-aventis, and the FDA, contributing to significant advancements in drug registration and clinical development throughout a distinguished career that began with an oncology fellowship at the National Cancer Institute.